Searched for
PHARMA UNDERPERFORMANCE
Dalal Street Week Ahead: Will Nifty hold 23,000 as markets test key support?The markets ended lower this week, with Nifty trading below its 50 and 100-week moving averages. While a crucial support zone near 23,000-2...
Q4 earnings review: Motilal Oswal highlights broad-based beat on estimates, lists 6 sectors that exceeded expectationsMotilal Oswal said Q4 FY26 earnings surpassed expectations, with aggregate profits rising 16% year-on-year against its 8% estimate. Strong ...
Dalal Street Week Ahead: Nifty stuck in consolidation zone; 23,800 remains key breakout hurdleMarkets experienced volatility and ended the week with a modest loss, primarily due to MSCI rebalancing flows. Nifty consolidated within a ...
As doomsday predictions become routine, India's forgotten smallcaps dole out 7 multibaggers in just 60 daysIndia's smallcap stocks have staged a remarkable comeback, delivering multibagger returns in just two months. Many beaten-down companies ha...
Sentiment is broken, fundamentals are not. PL Asset Management CIO says now is the time to buyIndian equity investors, frustrated by stagnant returns, are urged by Sandeep Neema of PL Asset Management to distinguish weak sentiment fr...
Nifty stays range-bound as resistance near 23,800 caps upside moveIndian markets ended the week with modest gains as Nifty remained range-bound, testing key resistance near 23,800 while volatility eased. T...
D-Street ends week in the green with war and peace on its mindFriday brought a wave of optimism to Indian stock markets, with notable weekly advancements. Nonetheless, investors remained watchful as ta...
Bernstein initiates coverage on 6 pharma stocks, cites 3 major tailwinds for healthcare sectorBernstein has initiated coverage on six Indian pharma stocks, with Zydus Lifesciences as its top choice. The brokerage sees strong future g...
Market wrap: Sensex rises 232 points, Nifty closes above 23,700 as rupee recovers from lifetime lowsIndian markets ended the week higher after recovering intraday volatility, with Sensex and Nifty posting modest gains amid hopes of easing ...
Nifty stuck in a range but small and midcaps are where real money is being made: Ashish ChaturmohtaIndian stock markets may appear stagnant, but opportunities exist in small and midcap stocks. JM Financial's Ashish Chaturmohta highlights ...
Nifty to trade in 28,000–30,000 range in FY27 led by earnings: Smallcase managersSmallcase managers remain optimistic on India’s equity markets despite the Nifty declining over 9% this year, projecting the benchmark inde...
Rising bond yields, oil prices keeping markets on edge; selective bets still emerging: Pankaj PandeyGlobal markets are under pressure due to rising bond yields and geopolitical tensions. Higher crude oil prices are a key concern, potential...
Markets rebound sharply: Sensex recovers 1,100 points from day’s low, Nifty closes near 23,650Sensex rose 1,100 points from its day’s low to close at 75,315, and Nifty 50 gained 333 points from its day’s low to end the session at 23,...
Mutual funds cut technology sector exposure to 8-year low in April. Is AI disruption reshaping sentiment?Mutual funds have significantly reduced their technology sector exposure to an eight-year low, driven by concerns over AI disruption, slowi...
Red alert: 15 stocks most vulnerable to FII selling as DIIs refuse to step inForeign institutional investors have divested approximately $53 billion from Indian equities since September 2024, leading to significant o...
“Reallocate, Diversify, Reposition”: Ajay Srivastava flags rising macro risks for investorsIndian markets face rising macro risks from global shocks, currency pressure, and energy prices, impacting domestic consumption and corpora...
Is your portfolio FII-proof? 7 stocks Jefferies says can defy the $53 billion foreign selloffForeign investors have divested $53 billion from Indian equities since late 2024, leading to underperformance against emerging markets. Dom...
Why market rose today? Sensex rises 790 points, Nifty closes near 23,700. 5 key drivers behind surgeIndian stock markets are experiencing a significant rally. The BSE Sensex and Nifty 50 indices have climbed over 1 percent each. This surge...
Cohance Lifesciences shares slip 7% after Jefferies cuts target price, downgrades on weak Q4Cohance Lifesciences shares dropped significantly after reporting an 84% year-on-year decline in March-quarter net profit. Jefferies downgr...
Sensex dips 3,400 points in 4 days. Is this the beginning of a bigger crash?Indian equity markets fell for a fourth straight session as rising crude oil prices, geopolitical tensions, FII selling, and a record-low r...